Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Susceptibility-Guided vs Empirical Therapy for Refractory H. pylori
NCT04332848Phase 4Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2020
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levofloxacin, tetracycline, rifabutin, clarithromycin, bismuth subsalicylate in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Started Jul 2020; status: recruiting.
02
Drugs
levofloxacintetracyclinerifabutinclarithromycinbismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04332848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04332848.